Dr. Michael Green interviews Dennis Edmonds, CEO of Kazera Global

July 5, 2022 | Posted by

Dr. Michael Green, resources analyst at Align Research, interviews Dennis Edmonds, CEO of Kazera Global

Key questions posed:

1 – Can you update shareholders with what activity is happening on the ground down in Namibia following your recent visit?

2 – Ditto ref the SA operations and any likely resolution to the HMS licence that has been awaited for many months now? 

3 – When do you expect the DD period to complete ref the new Rare Earth’s projects?

4 – We note continued erosion in the stock price since the recent oversubscribed capital raising of @ £1m – what message do you have to shareholders at this point?

5-  Please could you outline the news flow that is expected over the coming months?

Click the play button below to listen to the audio.


To read our recent coverage on Kazera CLICK HERE

Kazera Global is a research client of Align Research. Align Research is the largest shareholder in Kazera Global and cannot be seen to be impartial in relation to the share price outcome. All employees and analysts are bound to the company’s dealing policy ensuring open and adequate disclosure. Full details can be found on our website here (“Legals”).

This is a marketing communication and cannot be considered independent research. Nothing in this report should be construed as advice, an offer, or the solicitation of an offer to buy or sell securities by us. As we have no knowledge of your individual situation and circumstances the investment(s) covered may not be suitable for you. You should not make any investment decision without consulting a fully qualified financial advisor.

Your capital is at risk by investing in securities and the income from them may fluctuate. Past performance is not necessarily a guide to future performance and forecasts are not a reliable indicator of future results. The marketability of some of the companies we cover is limited and you may have difficulty buying or selling in volume. Additionally, given the smaller capitalisation bias of our coverage, the companies we cover should be considered as high risk. You should also assume, given that the majority of Align’s fees are received in stock, that for general corporate cash management purposes including taxation, that divestments of investments held will take place as and when, in Align’s sole discretion, it is deemed appropriate.

This financial promotion has been approved by Align Research Limited